2023 annual financial data
vTv Therapeutics 2023 Operating cash flow growth
Direct answer
Operating cash flow growth was -25.15%.
Operating income was -25,502,000 USD and net income was -20,250,000 USD.
Operating cash flow was -19,081,000 USD.
Get free vTv Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 9,000 USD
- Operating income
- -25,502,000 USD
- Net income
- -20,250,000 USD
- Operating cash flow
- -19,081,000 USD